Scientists from six major corporations will participate. In another research matter, trustees authorized the vice president for research to transfer to Douglas Kniss, an associate professor of obstetrics and gynecology, an exclusive license to use or develop a gene therapy-based treatment protocol. The protocol, known as Antisense DNA Strategies to Suppress Preterm Labor, was developed by Kniss and Ohio State has applied for a patent on the discovery. The license agreement is to provide compensation to the university. The agreement is a pilot project for the Small Business Technology Transfer Program.
All documents are the responsibility of their originator.